Literature DB >> 19349210

The pathophysiology of vivax malaria.

Nicholas M Anstey1, Bruce Russell, Tsin W Yeo, Ric N Price.   

Abstract

Long considered a benign infection, Plasmodium vivax is now recognized as a cause of severe and fatal malaria, despite its low parasite biomass, the increased deformability of vivax-infected red blood cells and an apparent paucity of parasite sequestration. Severe anemia is associated with recurrent bouts of hemolysis of predominantly uninfected erythrocytes with increased fragility, and lung injury is associated with inflammatory increases in alveolar-capillary membrane permeability. Although rare, vivax-associated coma challenges our understanding of pathobiology caused by Plasmodium spp. Host and parasite factors contribute to the risk of severe disease, and comorbidities might contribute to vivax mortality. In this review, we discuss potential mechanisms underlying the syndromes of uncomplicated and severe vivax malaria, identifying key areas for future research.

Entities:  

Mesh:

Year:  2009        PMID: 19349210     DOI: 10.1016/j.pt.2009.02.003

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  184 in total

1.  Renal cortical necrosis and acute kidney injury associated with Plasmodium vivax: a neglected human malaria parasite.

Authors:  Vivek B Kute; Aruna V Vanikar; Pramod P Ghuge; Jitendra G Goswami; Mohan P Patel; Himanshu V Patel; Manoj R Gumber; Pankaj R Shah; Hargovind L Trivedi
Journal:  Parasitol Res       Date:  2012-06-06       Impact factor: 2.289

Review 2.  Review: Malaria chemoprophylaxis for travelers to Latin America.

Authors:  Laura C Steinhardt; Alan J Magill; Paul M Arguin
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

3.  Defying malaria: Fathoming severe Plasmodium vivax disease.

Authors:  Quique Bassat; Pedro L Alonso
Journal:  Nat Med       Date:  2011-01       Impact factor: 53.440

4.  Glycophorin C (CD236R) mediates vivax malaria parasite rosetting to normocytes.

Authors:  Wenn-Chyau Lee; Benoit Malleret; Yee-Ling Lau; Marjorie Mauduit; Mun-Yik Fong; Jee Sun Cho; Rossarin Suwanarusk; Rou Zhang; Letusa Albrecht; Fabio T M Costa; Peter Preiser; Rose McGready; Laurent Renia; Francois Nosten; Bruce Russell
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

5.  Immunogenicity and antigenicity of Plasmodium vivax merozoite surface protein 10.

Authors:  Yang Cheng; Bo Wang; Jetsumon Sattabongkot; Chae Seung Lim; Takafumi Tsuboi; Eun-Taek Han
Journal:  Parasitol Res       Date:  2014-04-25       Impact factor: 2.289

6.  Vivax malaria: old drug, new uses?

Authors:  Bill Watkins; Carol Sibley
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

Review 7.  Respiratory Complications of Plasmodium vivax Malaria: Systematic Review and Meta-Analysis.

Authors:  Fernando Val; Kim Machado; Lisiane Barbosa; Jorge Luis Salinas; André Machado Siqueira; Maria Graças Costa Alecrim; Hernando Del Portillo; Quique Bassat; Wuelton Marcelo Monteiro; Marcus Vinícius Guimarães Lacerda
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

Review 8.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

9.  Analysis of the causes of spawning of large-scale, severe malarial epidemics and their rapid total extinction in western Provence, historically a highly endemic region of France (1745-1850).

Authors:  Emeline Roucaute; George Pichard; Eric Faure; Manuela Royer-Carenzi
Journal:  Malar J       Date:  2014-02-28       Impact factor: 2.979

10.  Evaluation of Plasmodium vivax HAP2 as a transmission-blocking vaccine candidate.

Authors:  Yue Qiu; Yan Zhao; Fei Liu; Bo Ye; Zhenjun Zhao; Sataporn Thongpoon; Wanlapa Roobsoong; Jetsumon Sattabongkot; Liwang Cui; Qi Fan; Yaming Cao
Journal:  Vaccine       Date:  2020-02-21       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.